US Map / New York
State NY

Clinical Trials in New York

Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.

Total Trials
668
Recruiting Now
668
← Back to US Map
Top Conditions in New York
Breast Cancer (20)Prostate Cancer (14)Endometrial Cancer (11)Ovarian Cancer (9)Colorectal Cancer (9)Advanced Solid Tumor (9)Malignant Solid Neoplasm (8)Acute Myeloid Leukemia (8)Lung Cancer (7)Cancer (7)Multiple Myeloma (7)Obesity (6)
NCT06901687 Phase 2
Recruiting
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Mult...
Condition
Multiple Sclerosis
Enrollment
170 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT07159633 N/A
Recruiting
OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Expe...
Condition
Relationship Conflict
Enrollment
120 pts
Location
United States
Sponsor
OurRelationship
View Trial →
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT07133984 N/A
Recruiting
STICH3C Cardiac Magnetic Resonance Observational Study
Condition
Ischemic Left Ventricle Systolic Dysfunction
Enrollment
200 pts
Location
United States, Austria, Canada
Sponsor
Weill Medical College of Corne
View Trial →
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT04965064 Phase 2
Recruiting
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic B...
Condition
Breast Cancer
Enrollment
22 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06780709 N/A
Recruiting
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NM...
Condition
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Enrollment
20 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
View Trial →
NCT07214298 Phase 1, Phase 2
Recruiting
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metas...
Condition
Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
View Trial →
NCT06340711 Phase 2
Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophago...
Condition
Esophageal Adenocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne
View Trial →
NCT05787834 N/A
Recruiting
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients U...
Condition
Breast Carcinoma
Enrollment
130 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
View Trial →
NCT05190471 Phase 1
Recruiting
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Le...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
48 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
View Trial →
NCT05884944 N/A
Recruiting
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Char...
Condition
Parkinson Disease
Enrollment
20 pts
Location
United States
Sponsor
New York Institute of Technolo
View Trial →
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
View Trial →
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04706663 N/A
Recruiting
Precision-Based Genomics in Prostate Cancer
Condition
Prostate Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
View Trial →
NCT07216521 N/A
Recruiting
Intent of Surgery for IPMN
Condition
Intraductal Papillary Mucinous Neoplasm
Enrollment
2,000 pts
Location
United States, China, Germany
Sponsor
NYU Langone Health
View Trial →
NCT07478393 N/A
Recruiting
Readiness and Progress in Emotion Regulation Therapy
Condition
Rumination
Enrollment
36 pts
Location
United States
Sponsor
Teachers College, Columbia Uni
View Trial →
NCT07477236 N/A
Recruiting
MyVitalC: Sleep and Everyday Headache Management
Condition
Sleep
Enrollment
100 pts
Location
United States
Sponsor
Efforia, Inc
View Trial →
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
View Trial →
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
View Trial →
NCT05341544 N/A
Recruiting
Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes
Condition
Premature Ventricular Contraction
Enrollment
60 pts
Location
United States
Sponsor
Northwell Health
View Trial →
NCT05673499 N/A
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major...
Condition
Congenital Disorders
Enrollment
900 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
View Trial →
NCT04742621 N/A
Recruiting
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
Condition
Unresectable Liver-limited Colorectal Metastases
Enrollment
20 pts
Location
United States
Sponsor
Weill Medical College of Corne
View Trial →
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
View Trial →
Page 1 of 27 — 668 trials total
Next →